DOI: 10.1055/s-00000030

Der Klinikarzt

LinksSchließen

Referenz

Sledge Jr GW, Toi M, Neven P. et al.
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy.

J Clin Oncol 2017;
35: 2875-2884

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: